Search Results

March 26, 2012

XARELTO® (rivaroxaban) Demonstrates Comparable Efficacy to Standard of Care for the Treatment and Secondary Prevention of Venous Blood Clots in Patients with Symptomatic Pulmonary Embolism in Pivotal Phase 3 Study

Rivaroxaban Showed Similar Safety Profile with Significantly Fewer Major Bleeds vs. Standard of Care Phase 3 Study Presented as Late-Breaker at the American College of Cardiology Annual Scientific Sessions and Published in the New England Journal of Medicine

Innovative Medicine

March 22, 2012

Investigational Study May Help Researchers Develop Test That Predicts Risk of Imminent Heart Attacks

Innovative Medicine

March 8, 2012

Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

Second ZYTIGA Phase 3 Study to be Unblinded, Based on Unanimous Recommendation of Independent Data Monitoring Committee

Innovative Medicine

February 27, 2012

New Patient Guidebook, “Live Healthier – Weight Loss Options for Treating Obesity,” Now Offered by the American College of Physicians Foundation

Guidebook and DVD Help Patients Learn About Obesity and Available Treatment Options

Innovative Medicine

February 27, 2012

U.S. FDA Grants Priority Review For XARELTO® (Rivaroxaban) To Reduce Secondary Cardiovascular Events In Patients With Acute Coronary Syndrome

Innovative Medicine

January 26, 2012

Janssen Healthcare Innovation Announces JANSSEN CONNECTED CARE CHALLENGE to Spur Innovation in Patient Care

Janssen Connected Care Challenge seeks transformational transition care ideas and offers awards totaling $250,000 to develop winning solutions

Innovative Medicine

January 26, 2012

Alzheimer’s Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care

New Challenge Seeks Simple, Widely-Adaptable Tools to Track Alzheimer’s Progression and Support HHS “Triple Aim” of Better Care and Better Health at Lower Cost

Research

January 17, 2012